KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $105.4 billion.

  • AbbVie's Non-Current Assets fell 888.82% to $105.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $431.3 billion, marking a year-over-year decrease of 94.63%. This contributed to the annual value of $109.6 billion for FY2024, which is 773.78% up from last year.
  • As of Q3 2025, AbbVie's Non-Current Assets stood at $105.4 billion, which was down 888.82% from $107.9 billion recorded in Q2 2025.
  • Over the past 5 years, AbbVie's Non-Current Assets peaked at $123.9 billion during Q1 2021, and registered a low of $101.7 billion during Q4 2023.
  • For the 5-year period, AbbVie's Non-Current Assets averaged around $111.6 billion, with its median value being $110.0 billion (2024).
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 21422.12% in 2021, then plummeted by 888.82% in 2025.
  • AbbVie's Non-Current Assets (Quarter) stood at $118.6 billion in 2021, then decreased by 6.96% to $110.3 billion in 2022, then decreased by 7.82% to $101.7 billion in 2023, then increased by 7.74% to $109.6 billion in 2024, then decreased by 3.85% to $105.4 billion in 2025.
  • Its last three reported values are $105.4 billion in Q3 2025, $107.9 billion for Q2 2025, and $108.5 billion during Q1 2025.